David Propper
- Internal Medicine top 2%
- Oncology top 2%
- Pancreatic and Hepatic Oncology Research 17
- Colorectal Cancer Treatments and Studies 9
- Cancer Treatment and Pharmacology 7
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism 9
- Cancer Genomics and Diagnostics 6
- Immunology top 5%
- Hematology top 5%
- Blood groups and transfusion 7
-
- Glioma Diagnosis and Treatment 6
-
- Cancer Research and Treatments 6
- Co-authors
- Frances R. BalkwillAdrian L. HarrisJeremy BraybrookeTrivadi S. GanesanDenis TalbotRoger FeakinsKenneth J. O’ByrneJonathan Shamash
- Journals
- British Journal of Cancer (10 papers)Journal of Clinical Oncology (10 papers)Annals of Oncology (7 papers)
- Partner nations
- United KingdomUnited StatesSwitzerland
In The Last Decade
David Propper
74 papers receiving 3.1k citations
Hit Papers
Peers
Comparison fields: 5 of 129
- Internal Medicine 205
- Oncology 1.3k
- Cancer Research 532
- Immunology 662
- Hematology 252
Countries citing papers authored by David Propper
This map shows the geographic impact of David Propper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Propper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Propper more than expected).
Fields of papers citing papers by David Propper
This network shows the impact of papers produced by David Propper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Propper. The network helps show where David Propper may publish in the future.
Co-authorship network
The 25 scholars most cited alongside David Propper, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 4 | |
| 2 | 2022 | 9 | |
| 3 | Harnessing cytokines and chemokines for cancer therapybreakdown → | 2022 | 651 |
| 4 | 2018 | 96 | |
| 5 | 2014 | 25 | |
| 6 | 2011 | 177 | |
| 7 | 2011 | 234 | |
| 8 | 2004 | 19 | |
| 9 | 2003 | 41 | |
| 10 | 2003 | 46 | |
| 11 | 2000 | 13 | |
| 12 | 2000 | 14 | |
| 13 | 2000 | 18 | |
| 14 | Phase I study of the novel cyclic AMP (cAMP) analogue 8-chloro-cAMP in patients with cancer: toxicity, hormonal, and immunological effects. | 1999 | 47 |
| 15 | 1999 | 103 | |
| 16 | 1992 | 9 | |
| 17 | 1991 | 2 | |
| 18 | 1991 | 3 | |
| 19 | 1991 | 1 | |
| 20 | Relative effects of major and minor histocompatibility locus antigens on the generation of suppressor activity by blood transfusions. | 1991 | 1 |
About David Propper
David Propper is a scholar working on Oncology, Transplantation and Cancer Research, having authored 78 papers that have together received 3.1k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (17 papers), Cancer, Hypoxia, and Metabolism (9 papers), Colorectal Cancer Treatments and Studies (9 papers), Cancer Treatment and Pharmacology (7 papers), Blood groups and transfusion (7 papers), Glioma Diagnosis and Treatment (6 papers), Cancer Genomics and Diagnostics (6 papers) and Cancer Research and Treatments (6 papers). The work is most often cited by research in Internal Medicine (205 citations), Oncology (1.3k citations) and Cancer Research (532 citations). David Propper has collaborated with scholars based in United Kingdom, United States and Switzerland. Frequent co-authors include Frances R. Balkwill, Adrian L. Harris, Jeremy Braybrooke, Trivadi S. Ganesan, Denis Talbot, Roger Feakins, Kenneth J. O’Byrne, Jonathan Shamash, Eric Gardiner and Joseph Sgouros. Their work appears in journals such as British Journal of Cancer, Journal of Clinical Oncology, Annals of Oncology, Cancer Research and Transplantation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.